Microfluidic Production and Characterisation of Cyclosporine A-Loaded Lipid–Chitosan Hybrid Nanoparticles as Candidate Pulmonary Drug Delivery Systems
The microfluidic approach enabled the production of nanoparticles with controlled sizes below 200 nm, narrow size distributions, and good reproducibility that support further investigation of microfluidic-produced lipid and hybrid nanoparticles as candidate platforms for pulmonary drug delivery.